Friday 25th September 2009 |
Text too small? |
Shares in ANZ, ING Medical Properties Trust, and ING Property Trust were all placed on a trading halt on the NZX and ASX prior to announcement of the A$1.76 billion (1.1 billion euros) deal in which Australasia's largest bank will mop up the remaining half of the ING funds management business.
The companies involved are ING Australia and ING New Zealand and the transaction values the two entities at 11 times normalised 2008 earnings and 1.2 times embedded value at December 31, the ANZ said in a media statement.
"The transaction is expected to be cash earnings per share accretive in FY2010 pre-synergy benefits." ANZ would become the third largest player in the Australian life insurance market, fifth in Australia and first in New Zealand for funds management, and would provide more flexible opportunities to pursue wealth management opportunities.
The purchase played to ANZ's strategy of taking advantage of the global financial crisis and ANZ's strong balance sheet to pursue growth, said ANZ CEO Mike Smith.
The future use of the ING brand in either market has yet to be determined. The transaction is subject to regulatory approvals in both countries and is targeted for completion before the end of the year.
The managers of the property trusts are fully owned by ING New Zealand. ING Groep NV, the ultimate parent of the Australasian subsidiaries, has been selling assets after it received 10 billion euro from the Dutch government in the wake of the credit crisis.
Shares in ANZ rose 1.3% to $28.40 on the NZX when the trading halt lifted, while ING Medical Property Trust was at $1.16 and ING Property Trust was 81 cents.
Businesswire.co.nz
No comments yet
December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors